Tompkins Financial Corp Abbott Laboratories Transaction History

Tompkins Financial Corp

$1.02 Billion
Q1 2025

A detailed history of Tompkins Financial Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Tompkins Financial Corp holds 104,880 shares of ABT stock, worth $13.5 Million. This represents 1.36% of its overall portfolio holdings.

Number of Shares

104,880

Previous 104,215 0.64%

Holding current value

$13.5 Million

Previous $11.8 Million 18.03%

% of portfolio

1.36%

Previous 1.11%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 07, 2025	BUY	$111.1 - $140.22 $73,881 - $93,246	665 Added 0.64%	104,880 $13.9 Million
Q4 2024 Jan 15, 2025	BUY	$111.93 - $119.39 $269,751 - $287,729	2,410 Added 2.37%	104,215 $11.8 Million
Q3 2024 Nov 01, 2024	BUY	$100.07 - $118.13 $8,305 - $9,804	83 Added 0.08%	101,805 $11.6 Million
Q2 2024 Jul 17, 2024	SELL	$100.73 - $112.44 $29,513 - $32,944	-293 Reduced 0.29%	101,722 $10.6 Million
Q1 2024 Apr 08, 2024	BUY	$109.52 - $120.96 $51,693 - $57,093	472 Added 0.46%	102,015 $11.6 Million
Q4 2023 Jan 08, 2024	BUY	$90.19 - $110.4 $820,999 - $1 Million	9,103 Added 9.85%	101,543 $11.2 Million
Q3 2023 Nov 20, 2023	BUY	$95.53 - $114.62 $686,000 - $823,086	7,181 Added 8.42%	92,440 $8.95 Million
Q2 2023 Jul 12, 2023	SELL	$100.78 - $112.29 $239,150 - $266,464	-2,373 Reduced 2.71%	85,259 $9.29 Million
Q1 2023 Apr 20, 2023	BUY	$96.86 - $114.01 $61,990 - $72,966	640 Added 0.74%	87,632 $8.87 Million
Q4 2022 Jan 06, 2023	SELL	$95.06 - $111.52 $108,558 - $127,355	-1,142 Reduced 1.3%	86,992 $9.55 Million
Q3 2022 Oct 13, 2022	BUY	$96.76 - $112.03 $11,417 - $13,219	118 Added 0.13%	88,134 $8.53 Million
Q2 2022 Jul 14, 2022	BUY	$102.07 - $123.37 $26,844 - $32,446	263 Added 0.3%	88,016 $9.56 Million
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $2.75 Million - $3.35 Million	24,118 Added 37.9%	87,753 $10.4 Million
Q4 2021 Jan 24, 2022	SELL	$115.53 - $141.46 $51,872 - $63,515	-449 Reduced 0.7%	63,635 $8.96 Million
Q3 2021 Oct 22, 2021	SELL	$116.66 - $129.06 $175,806 - $194,493	-1,507 Reduced 2.3%	64,084 $7.57 Million
Q1 2021 Jun 09, 2021	BUY	$108.84 - $128.23 $15,455 - $18,208	142 Added 0.22%	65,591 $7.86 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $8.19 Million - $8.93 Million	-78,039 Reduced 54.39%	65,449 $7.17 Million
Q4 2020 Feb 05, 2021	BUY	$105.0 - $114.42 $8.61 Million - $9.38 Million	81,960 Added 133.21%	143,488 $11.3 Million
Q3 2020 Oct 23, 2020	BUY	$91.64 - $111.29 $23,643 - $28,712	258 Added 0.42%	61,528 $6.7 Million
Q2 2020 Jul 29, 2020	BUY	$76.57 - $98.0 $154,824 - $198,156	2,022 Added 3.41%	61,270 $5.6 Million
Q1 2020 Apr 22, 2020	SELL	$62.82 - $91.86 $70,546 - $103,158	-1,123 Reduced 1.86%	59,248 $4.67 Million
Q4 2019 Jan 22, 2020	BUY	$78.51 - $87.4 $154,193 - $171,653	1,964 Added 3.36%	60,371 $5.24 Million
Q3 2019 Oct 17, 2019	SELL	$81.84 - $88.74 $45,257 - $49,073	-553 Reduced 0.94%	58,407 $4.89 Million
Q2 2019 Jul 17, 2019	SELL	$72.88 - $85.0 $149,404 - $174,250	-2,050 Reduced 3.36%	58,960 $4.96 Million
Q1 2019 Apr 30, 2019	BUY	$66.22 - $80.06 $3.64 Million - $4.4 Million	54,973 Added 910.6%	61,010 $4.88 Million
Q1 2019 Apr 17, 2019	SELL	$66.22 - $80.06 $102,972 - $124,493	-1,555 Reduced 20.48%	6,037 $443,000
Q4 2018 Jan 22, 2019	BUY	$65.56 - $74.27 $101,945 - $115,489	1,555 Added 25.76%	7,592 $549,000
Q2 2018 Jul 18, 2018	BUY	$57.57 - $63.54 $81,461 - $89,909	1,415 Added 30.61%	6,037 $368,000
Q1 2018 Apr 26, 2018	SELL	$56.27 - $63.62 $1,463 - $1,654	-26 Reduced 0.56%	4,622 $277,000
Q4 2017 Jan 24, 2018	SELL	$53.68 - $57.47 $1.06 Million - $1.14 Million	-19,804 Reduced 80.99%	4,648 $266,000
Q3 2017 Oct 17, 2017	BUY	$48.06 - $53.64 $1.18 Million - $1.31 Million	24,452	24,452 $1.3 Million

Others Institutions Holding ABT

# of Institutions

3,440

Shares Held

1.34B

Call Options Held

10.5M

Put Options Held

8.72M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $226B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tompkins Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Tompkins Financial Corp with notifications on news.

Account

Tompkins Financial Corp Abbott Laboratories Transaction History